Resources

4 Resources for

aaron f. barkoff

Subscribe to this listing via:
RSS
Email

BNET Resources

Federal Circuit Affirms Fee Award to Takeda: Aaron F. Barkoff submits: Takeda v. Mylan and Alphapharm, Nos. 2007-1269, -1270 (Fed. Cir. 2008) In an opinion released Monday, the Federal Circuit affirmed a district court decision granting $16.8 million for attorney fees, expenses and expert fees to Takeda (TKPHF.PK) for baseless paragraph IV certification letters...; Tags: Biotech, Aaron F. Barkoff, Mylan Inc.; External links 2008-12-09
Federal Circuit Affirms Extension of Stay Against Teva's Generic Evista: Aaron F. Barkoff submits: Eli Lilly & Co. LLY v. Teva Pharms. TEVA USA, Inc., No. 2009–1071 (Fed. Cir. 2009) Under the Hatch-Waxman Act, final FDA approval of an ANDA is automatically stayed for thirty months when a patent owner files suit for patent infringement within 45 days of...; Tags: Healthcare, Aaron F. Barkoff, Eli Lilly & Co.; External links 2009-02-25
Supreme Court Denies Aventis' Cert Petition in Lovenox Case: Aaron F. Barkoff submits: Aventis Pharma v. Amphastar and Teva, S. Ct. Appeal No. 08-937 (2009) The Supreme Court on Monday denied Aventis Pharma's SNY cert petition in a long-running dispute with generic biopharmaceutical manufacturer Amphastar. In its petition, Aventis had asked the Court to review...; Tags: Biotech, Aaron F. Barkoff, Sanofi-Aventis; External links 2009-04-28
Bayer Patent on Yasmin Affirmed Invalid: Aaron F. Barkoff submits: Bayer Schering v. Barr Labs, No. 2008-1282 (Fed. Cir. 2009) A divided panel of the Federal Circuit affirmed a district court decision holding Bayer's (BYERF.PK) U.S. Patent No. 6,787,531 invalid due to obviousness. The '531 patent, which claims pharmaceutical compositions of drospirenone and ethinyl...; Tags: Healthcare, Aaron F. Barkoff; External links 2009-08-06

Additional Resources

District Court Affirms Dismissal of Prasco's Declaratory Judgment Suit Against Medicis: Aaron F. Barkoff submits: Prasco v. Medicis Pharm. Corp., No. 2007-1524 (Fed. Cir. 2008) Medicis markets a benzoyl peroxide cleansing product, Triaz. Prasco sells a competing benzoyl peroxide cleansing product, Oscion. Prasco filed a declaratory judgment complaint, requesting judgment that Oscion does not infringe four patents owned or licensed by Medicis...; Tags: Biotech; External links 2008-10-07

Federal Circuit Affirms Merck?s Victory in Trusopt/Cosopt Case: Aaron F. Barkoff submits: Merck & Co. v. Apotex, No. 2008-1133 (Fed. Cir. 2008) In 2005, Hi-Tech Pharmacal HITK became the first company to file a paragraph IV certification relating to Merck's MRK glaucoma drugs Trusopt and Cosopt. Hi-Tech filed paragraph IV certifications with respect to all three...; Tags: Biotech; External links 2008-10-10